SV Life Sciences Fund IV (GP), L.P., 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 2,136 shares at $20.02 ($43K) on 2018-12-19, disclosed to the SEC on 2018-12-21.
Open-market sale of $43k KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 59 | $1K | 2.8% |
| 2 | $20.02 | 2,077 | $42K | 97.2% |
| Total | $20.02 avg | 2,136 | $43K | 100% |
| Filing → |
| NGSX | SELL | 2010-05-05 | $3.1M | — | Filing → |